Page last updated: 2024-11-12
preprotachykinin b (50-79)
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
preprotachykinin B (50-79): amino acid sequence given in first source; found in both neurokinin B and preprotachykinin B [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 16131046 |
MeSH ID | M0214324 |
Synonyms (8)
Synonym |
---|
l-leucyl-l-tyrosyl-l-alpha-aspartyl-l-seryl-l-arginyl-l-seryl-l-isoleucyl-l-seryl-l-leucyl-l-alpha-glutamylglycyl-l-leucyl-l-leucyl-l-lysyl-l-valyl-l-leucyl-l-seryl-l-lysyl-l-alanyl-l-seryl-l-valylglycyl-l-prolyl-l-lysyl-l-alpha-glutamyl-l-threonyl-l-sery |
preprotachykinin b (50-79) |
nkb peptide 2 |
nkb-p2 |
148597-04-0 |
l-glutamine, l-leucyl-l-tyrosyl-l-alpha-aspartyl-l-seryl-l-arginyl-l-seryl-l-isoleucyl-l-seryl-l-leucyl-l-alpha-glutamylglycyl-l-leucyl-l-leucyl-l-lysyl-l-valyl-l-leucyl-l-seryl-l-lysyl-l-alanyl-l-seryl-l-valylglycyl-l-prolyl-l-lysyl-l-alpha-glutamyl-l-th |
peptide 2, neurokinin b |
DTXSID70164027 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.41
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.41) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |